Global Influenza Vaccine Market Size to Boost USD 13.7 Billion By 2032 | CAGR 7.2%

DELHI, India - Oct. 30, 2024 - PRLog -- Global Influenza Vaccines Market and Forecasts 2024 – 2032" presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global influenza vaccines market. The report also provides up-to-date historical market size data for the period 2018 – 2023 and an illustrative forecast to 2032 covering key market aspects like market value, volume analysis, and trends for influenza vaccines globally.

The report will serve as a source for a 360-degree analysis in which various models will be thoroughly integrated. After a thorough study of the historical and current growth parameters, the growth prospects of the global influenza vaccines market are determined with utmost precision.

Key and Emerging Players in the Global Influenza Vaccines Market are Listed Below:

1. Sanofi Pasteur
2. GlaxoSmithKline (GSK)
3. Seqirus (CSL Limited)
4. AstraZeneca
5. Mylan(Viatris)
6. BioDiem
7. Novavax
8. Medicago
9. Moderna Inc
10. Pneumagen
11. Daiichi–Sankyo
12. Altimmune
13. FluGen
14. Imutex
15. EpiVax
16. Osivax
17. Emergex Vaccines
18. Versatope Therapeutics, Inc.
19. BIKEN Co., Ltd.
20. Gamma Vaccines Pty Ltd.
21. BiondVax Pharmaceuticals Ltd.
22. Hualan Biological Engineering Inc.
23. Shanghai Institute of Biological Products Co., Ltd.

More Information: https://dpiresearch.com/report/global-influenza-vaccines-...